Shift of phenotypic profile in a patient with acute myeloid leukemia after allogeneic transplant: an open issue for minimal residual disease assessment
Drugs and Cell Therapies in Hematology · 2013
DOI: 10.4081/dcth.2013.168 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs and Cell Therapies in Hematology, 2013. Verfasst von I. Cutini und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cutini, I., Mannelli, F., Bencini, S., Gianfaldoni, G., Guidi, S., & Bosi, A. (2013). Shift of phenotypic profile in a patient with acute myeloid leukemia after allogeneic transplant: an open issue for minimal residual disease assessment. Drugs and Cell Therapies in Hematology. https://doi.org/10.4081/dcth.2013.168
Vancouver
Cutini I, Mannelli F, Bencini S, Gianfaldoni G, Guidi S, Bosi A. Shift of phenotypic profile in a patient with acute myeloid leukemia after allogeneic transplant: an open issue for minimal residual disease assessment. Drugs and Cell Therapies in Hematology. 2013. doi:10.4081/dcth.2013.168
BibTeX
@article{Cutini2013,
author = {Cutini, I. and Mannelli, F. and Bencini, S. and Gianfaldoni, G. and Guidi, S. and Bosi, A.},
title = {Shift of phenotypic profile in a patient with acute myeloid leukemia after allogeneic transplant: an open issue for minimal residual disease assessment},
journal = {Drugs and Cell Therapies in Hematology},
year = {2013},
doi = {10.4081/dcth.2013.168}
}
EUVIMED